Walmart Inc. WMT,
Referenced Symbols
Read Next
Read Next
How much is Big Pharma making from COVID-19 vaccines? We’re about to find out
U.S. pharmaceutical companies are expected to collect more revenue from COVID-19 vaccines in the third quarter than they did in the entire first half of the year, and that money should continue to grow.
More On MarketWatch
- ‘I’d rather be a billionaire and not be loved by everybody’: Charlie Munger shrugs off controversy over $200M donation for nearly windowless dorm
- Moderna to Delay Request for Approval of Covid Vaccine in Children After FDA Asks for More Time
- Newsweek cover on vaccines for children slammed by health experts: ‘Why not add a foot-long needle for good measure?’
- A Huge Pension Sold Netflix, Bank of America, and Intel Stock. Here’s What It Bought.
About the Author
Tonya Garcia is a MarketWatch reporter covering retail and consumer-oriented companies. You can follow her on Twitter @tgarcianyc. She is based in New York. Tonya joined MarketWatch from Moguldom Media, where she was business editor for MadameNoire, a website targeting African-American women with a range of content from personal finance to economics, politics, education and lifestyle and entertainment. She also worked at Mediabistro, and previously handled media relations for MSLGroup’s consumer practice.
